Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 31


Mutant Ikzf1, KrasG12D, and Notch1 cooperate in T lineage leukemogenesis and modulate responses to targeted agents.

Dail M, Li Q, McDaniel A, Wong J, Akagi K, Huang B, Kang HC, Kogan SC, Shokat K, Wolff L, Braun BS, Shannon K.

Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):5106-11. doi: 10.1073/pnas.1001064107. Epub 2010 Mar 1.


Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.

De Bruin ML, Sparidans J, van't Veer MB, Noordijk EM, Louwman MW, Zijlstra JM, van den Berg H, Russell NS, Broeks A, Baaijens MH, Aleman BM, van Leeuwen FE.

J Clin Oncol. 2009 Sep 10;27(26):4239-46. doi: 10.1200/JCO.2008.19.9174. Epub 2009 Aug 10.


Secondary breast cancer in Hodgkin's lymphoma survivors.

Crump M, Hodgson D.

J Clin Oncol. 2009 Sep 10;27(26):4229-31. doi: 10.1200/JCO.2009.22.9120. Epub 2009 Aug 10. No abstract available.


Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model.

Alcantara Llaguno S, Chen J, Kwon CH, Jackson EL, Li Y, Burns DK, Alvarez-Buylla A, Parada LF.

Cancer Cell. 2009 Jan 6;15(1):45-56. doi: 10.1016/j.ccr.2008.12.006. Erratum in: Cancer Cell. 2009 Mar 3;15(3):240.


GammaH2AX and cancer.

Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, Pommier Y.

Nat Rev Cancer. 2008 Dec;8(12):957-67. doi: 10.1038/nrc2523. Epub 2008 Nov 13. Review.


Comprehensive genomic characterization defines human glioblastoma genes and core pathways.

Cancer Genome Atlas Research Network.

Nature. 2008 Oct 23;455(7216):1061-8. doi: 10.1038/nature07385. Epub 2008 Sep 4. Erratum in: Nature. 2013 Feb 28;494(7438):506.


Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease.

Basu SK, Schwartz C, Fisher SG, Hudson MM, Tarbell N, Muhs A, Marcus KJ, Mendenhall N, Mauch P, Kun LE, Constine LS.

Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):34-40. doi: 10.1016/j.ijrobp.2008.04.068.


Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose.

Constine LS, Tarbell N, Hudson MM, Schwartz C, Fisher SG, Muhs AG, Basu SK, Kun LE, Ng A, Mauch P, Sandhu A, Culakova E, Lyman G, Mendenhall N.

Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):24-33. doi: 10.1016/j.ijrobp.2008.04.067.


Response of intracerebral human glioblastoma xenografts to multifraction radiation exposures.

Ozawa T, Faddegon BA, Hu LJ, Bollen AW, Lamborn KR, Deen DF.

Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):263-70.


Activation of Akt and mTOR in CD34+/K15+ keratinocyte stem cells and skin tumors during multi-stage mouse skin carcinogenesis.

Affara NI, Trempus CS, Schanbacher BL, Pei P, Mallery SR, Bauer JA, Robertson FM.

Anticancer Res. 2006 Jul-Aug;26(4B):2805-20.


Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy.

Sharif S, Ferner R, Birch JM, Gillespie JE, Gattamaneni HR, Baser ME, Evans DG.

J Clin Oncol. 2006 Jun 1;24(16):2570-5.


Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation.

Zhu Y, Harada T, Liu L, Lush ME, Guignard F, Harada C, Burns DK, Bajenaru ML, Gutmann DH, Parada LF.

Development. 2005 Dec;132(24):5577-88.


Therapy-induced malignant neoplasms in Nf1 mutant mice.

Chao RC, Pyzel U, Fridlyand J, Kuo YM, Teel L, Haaga J, Borowsky A, Horvai A, Kogan SC, Bonifas J, Huey B, Jacks TE, Albertson DG, Shannon KM.

Cancer Cell. 2005 Oct;8(4):337-48.


Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.

Travis LB, Hill D, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Pukkala E, Lynch CF, Pee D, Smith SA, Van't Veer MB, Joensuu T, Storm H, Stovall M, Boice JD Jr, Gilbert E, Gail MH.

J Natl Cancer Inst. 2005 Oct 5;97(19):1428-37.


Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma.

Zhu Y, Guignard F, Zhao D, Liu L, Burns DK, Mason RP, Messing A, Parada LF.

Cancer Cell. 2005 Aug;8(2):119-30.


Neurofibromin is actively transported to the nucleus.

Vandenbroucke I, Van Oostveldt P, Coene E, De Paepe A, Messiaen L.

FEBS Lett. 2004 Feb 27;560(1-3):98-102.


Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder.

Le DT, Kong N, Zhu Y, Lauchle JO, Aiyigari A, Braun BS, Wang E, Kogan SC, Le Beau MM, Parada L, Shannon KM.

Blood. 2004 Jun 1;103(11):4243-50. Epub 2004 Feb 24.


Second cancers in survivors of childhood cancer.

Bhatia S, Sklar C.

Nat Rev Cancer. 2002 Feb;2(2):124-32. Review.


Neurofibromatosis 1: closing the GAP between mice and men.

Dasgupta B, Gutmann DH.

Curr Opin Genet Dev. 2003 Feb;13(1):20-7. Review.


GTPase activating proteins: critical regulators of intracellular signaling.

Donovan S, Shannon KM, Bollag G.

Biochim Biophys Acta. 2002 Mar 14;1602(1):23-45. Review. No abstract available.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk